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 Extended life expectancy in cancer nowadays has implication on longer 
exposures toward cancer-related stressors. Based on the adaptation theory, 
the longer the stressor exposures then the more the stress tolerance expected. 
This study aimed to compare and analyze the differences of stress and fear  
in cervical and breast cancer survivors (CCS and BCS) between cases and 
survivorship stages, impacting on anxiety, depression, and perceived life 
normality (PLN). This cross-sectional study involved 47 CCS and 58 BCS 
(n=105). Self-developed instrument was used in data collection  
(r=-0.256-0.935; Chronbach’s Alpha=0.908). Various statistical tests were 
used in data analysis (α<0.05). Stress due to cancer diagnosis and treatments 
were significantly different between cases (p=0.005 and p=0.003 in CCS and 
BCS respectively), impacting significant differences on anxiety, depression, 
and PLN between cases (p=0.025, p=0.000, and p=0.000 respectively).  
In both cases, stress due to cancer diagnosis and treatments, anxiety, 
depression, and PLN were not significantly different between survivorship 
stages (all p>0.05). Fear towards cancer recurrence, metastasis,  
additional cancer, and diagnostic test were not significantly different between 
cases and survivorship stages (all p>0.05). These findings argue  
the adaptation theory because the adaptation process was proved  
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Cancer involves certain genes controlling the cell regeneration process which damaged and grow 
abnormally [1]. Annually more than two million women globally are diagnosed with breast or cervical 
cancer, in which their housing, socioeconomic status, and agency dominantly determines whether she will 
develop one of these cancers and will ultimately survive [2]. The stage of survivorship in cancer categorizes 
into three, namely: acute (< 1 year), short term (1-5 years), and long term survivorship (> 5 years) [3].  
Indonesia cancer prevalence was 1.4% in 2013, in which 0.8‰ and 0.5‰ for breast and cervical 
cancer. The three highest prevalence provinces of cervical cancer were Riau Islands, North Maluku,  
and Yogyakarta (equal to 1.5‰), while the highest prevalence province of breast cancer was Yogyakarta 
(equal to 2.4‰); most women with breast and cervical cancer were found in East Java and Central Java 
provinces [4]. Breast cancer ranked highest for the new case and death in 2017, followed by cervical cancer  
in 2nd position [5] (detail explanation about Indonesia’s cancer profiling in 2017 was not available online yet). 
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Cervical and breast cancers have different etiology, symptoms, and complications. Cancer therapy 
mainly consists of surgery, chemotherapy and radiotherapy. Prior study result showed that the type of therapy 
between cervical and breast cancers were significantly different (p=.000) [6]. Cancer diagnosis and its 
treatments induce stress in cancer survivors with impacts on anxiety and depression; while diagnostic test,  
the possibility of additional cancer, cancer recurrence and metastasis induce fear in cancer survivors 
impacting perceived life normality (PLN) [7]. There is a specific neurocircuitry in our brain which linking 
stress to fear and anxiety involving amygdale and insular cortex activation [8]. There are three parts of brain 
which undergo stress-induced structural remodeling and cause the changes in behavioral and physiological 
responses: the hippocampus, amygdala, and prefrontal cortex [9]. Stress even could limit the efficacy  
of behavioral therapies aimed at limiting pathological fear [10]. 
The expert of stress research, Hans Selye, defined stress as a nonspecific body response to any 
demand [11]. Every stress may leave an ineradicable scar, and individual survives from stress by being older. 
His stress model, the General Adaptation Syndrome (GAS), stated that there were three stages of body 
response towards stress: alarm, resistance, and exhaustion [12].  
Adaptation and stress are two important concepts to be understood in order to understand better 
about individual behavior, especially for understanding the phases of illness [13]. Adaptation could be seen 
as a product and a process; as a product, adaptation cannot remain entirely faithful to its original form,  
while as a process, adaptation becomes an act of appropriating and salvaging while trying to give new 
meaning [14]. A well-known adaptation theory in the nursing world is the adaptation model of nursing which 
was developed by Sister Callista Roy in 1976. She assumed that a person is a bio-psycho-social being who  
is in constant interaction with a changing environment considered as an adaptive system. A person or groups 
who did adaptation means they use conscious awareness, self-reflection and choice to create human and 
environmental integration [15].  
The longer people live with cancer, the more exposure towards various types of stressor they 
encounter physically and psychologically. The longer the exposure towards stress will be the shorter 
the individual lifespan [16]. In unhealthy individuals, women living with cancer for instance, the longtime 
exposure towards stress may worsen their health status. Correlation between psychosocial stressors and 
disease is influenced by the stressors (its nature, number, and persistence) and the individual’s biological 
vulnerability (e.g. genetics, constitutional factors), psychosocial resources, and coping strategy [17].  
Gender also has significant effect towards stress and its management. Women are frequently report  
the elevated stress level compared to men with more physical and emotional symptoms appear, but they are 
doing a better job than men by connecting with others better; this connection is important for making stress 
management strategies [18].   
There is a big question about how long adaptation process happen, is there any maximum limit for 
that, in any context of life. The period of exposure towards stressors could determine individual stress 
tolerance due to adaptation process. Increase survivorship or longer life expectancy in cancer survivors have 
implication on longer stressor exposures by impact of prolonged psychological pain/suffering due to stress 
and fear, especially in long-term cancer survivors. Although stressor exposures may happen yearly in CCS 
and BCS, whether their stress/fear tolerances significantly improve over time along with the survivorship 
stages or not, it is still a big question mark. Based on the adaptation theory, it could be expected that 
individual stress tolerance will improve together with the progress in adaptation process. This study aimed  
to compare and analyze the differences of stress and fear in cervical and breast cancer survivors  
(CCS and BCS) between cases and stages of survivorship, with impact on anxiety, depression, and PLN.  
By knowing this study results, it will be beneficial for health care professionals in developing adequate 
multidisciplinary psychosocial intervention, and determining when is the best time to deliver it to CCS and 
BCS. It is important to address the psychological needs of cancer survivors to assure optimum HRQOL 
 
 
2. RESEARCH METHOD 
This cross-sectional study involved 47 CCS and 58 BCS in the district of Rangkah, Gading,  
and Pacarkeling, Surabaya, Indonesia, which consisted of 27, 45, and 33 acute, short-term, and long-term 
survivors. In this study, more cases of breast cancer were found (more than 50%). Since 2014 to present, 
breast cancer was the top leading case of female cancer in Indonesia. All study respondents expressed their 
agreement to participate in this study, and they had signed the consent form. Only adult, individual with 
confirmed cancer diagnosis, and individual on the list to be home visited regularly by palliative volunteer 
who were eligible to be study respondent. Those who were denied informed consent, very weak or totally bed 
rest, experienced extreme fatigue and losing conscious or disoriented were excluded from this study.  
Total sampling was applied so that sample size became 105. The head of palliative volunteer provided  
the patient’s data, and the volunteers accompanied the researcher in doing “door to door” data collection.  
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Self-developed instrument was used in data collection process. It consists of 9 items assessing stress 
(2 items), fear (4 items), anxiety (1 item), depression (1 item), and PLN (1 item). Psychological stress and 
fear in women living with cancer were assessed by the time of data collection (actual condition). Likert scale 
of 0 to 10 representing none to severe was used to distinguish individual response in each item: 1 
(none = 0, 2) mild = 1-3, 3) moderate = 4-6, and 4) severe = 7-10; but this category was made to ease the data 
presentation only in result section, and not for statistical analysis purposes. After instrument testing procedure, 
this instrument was proved to be valid and highly reliable (r = -0.256 - 0.935; Chronbach’s Alpha = 0.908). 
Data were collected since February until March, 2018. Ethical clearance was issued by Faculty  
of Nursing, Universitas Airlangga, Surabaya, Indonesia, with certificate number of 681-KEPK. 
Descriptive statistic, independent sample T, one way ANOVA, Mann-Whitney U,  
and Kruskal-Wallis H tests were used in data analysis (α < 0.05). Data of fear towards diagnostic test and 
additional cancer, and anxiety were normally distributed (p = 0.156, p = 0.059, and p = 0.155 respectively), 
therefore parametric test was used to analyse the data (independent sample T test and one way ANOVA).  
In the other hand, data of stress due to cancer diagnosis and treatments, fear towards cancer recurrence and 
metastasis, depression, and PLN were not normally distributed (all p<α), therefore nonparametric test was 
used to analyse the data (Mann-Whitney U and Kruskal-Wallis H tests). 
 
 
3. RESULTS AND DISCUSSION 
Most respondents were married women with lower-middle socioeconomic status, but better 
condition was found in the group of breast cancer. CCS was mostly older than BCS. Married CCS was 
mostly has no child, and more single women were found to be BCS in this study. Table 1 explains  
the demography characteristic of study respondents in details. The majority was long term survivors; 
therefore the survival rate of breast and cervical cancer is particularly long. Surgey was the top choice  
of therapy for BCS, while CCS was mostly underwent surgery and chemo-radiotherapy. Both cancer and its 
treatments were being long term stressors for most respondents. Table 2 explains the primary data of study 
respondents in details. Generally, cervical cancer resulted in worst stress and fear compared to breast cancer, 
but luckily high PLN was found most in both cases. BCS experienced less stress and fear compared to CCS, 
even “none” level was found in most variables. Depression and anxiety were found to be worst in CCS than 
BCS.  The majority of both respondents agreed that among all causes, diagnostic test was the only variable which 
was less feared by women living with cancer. Table 3 explains the specific data of study respondents in details. 
Stress due to cancer diagnosis and treatments were significantly different between cases  
(p=0.005 and p=0.003 respectively), impacting significant differences on anxiety, depression, and PLN 
between cases (p=0.025, p=0.000, and p=0.000 respectively); while fear towards cancer recurrence, 
metastasis, additional cancer, and diagnostic test were not significantly different between cases  
(p = 0.535, p = 0.795, p = 0.223, and p = 0.338 respectively). Table 4 explains the significant differences  
of stress, anxiety, depression, and PLN in both groups. 
Stress due to cancer diagnosis and treatments, anxiety, depression, and PLN were not significantly 
different between survivorship stages in both cases (CCS: p = 0.918, p = 0.244, p = 0.337, p = 0.257,  
and p = 0.518 respectively; BCS: p = 0.476, p = 0.335, p = 0.519, p = 0.384, and p = 0.091 respectively). 
Fear towards cancer recurrence, metastasis, additional cancer, and diagnostic test were also not significantly 
different between survivorship stages in both cases (CCS: p = 0.275, p = 0.432, p = 0.704, and p = 0.144 
respectively; BCS: p = 0.574, p = 0.645, p = 0.430, and p = 0.818 respectively). All study parameters were 
not significantly different between survivorship stages in both cases, indicating a very slow improvement  
of stress/fear tolerance in the long run of survivorship period. Table 5 (A and B) explains the result  
of statistical analysis in details. 
There are many life events inducing individual stress, one of them is physical disease, especially the 
chronic one [19]. Results showed that stress due to cancer diagnosis and treatments were significantly 
different between CCS and BCS (p=.005 and p=.003 respectively), impacting significant differences on 
anxiety, depression, and PLN between cases (p=.025, p=.000, and p=.000 respectively). In the other hand, 
fear towards cancer recurrence, metastasis, additional cancer, and diagnostic test were not significantly 
different between cases (all p > α). These findings indicate that stress due to cancer diagnosis and treatments, 
anxiety, depression, and PLN are more determined by cases compared to fear towards cancer recurrence, 
metastasis, additional cancer, and diagnostic test which are found to be relatively similar in CCS and BCS.  
 Stress due to cervical cancer diagnosis (80.85% severe stress) was found to be more severe than 
stress due to breast cancer diagnosis (48.28% severe stress). Both cervical and breast cancer are chronic 
disease, but they could induce different stress level in women. More severe stress was found in women living 
with cervical cancer (CCS). This possibly happened because many CCS perceived that sexual problem could 
happen due to cervical cancer. A study about distress in 41 long term CCS found that 50% respondents 
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reported negative impact on their life due to cervical cancer, such as significant decrements in sexual 
functioning; they perceived that sexual problems is the direct result of cervical cancer [20]. In cervical 
cancer, vaginal bleeding can occur after intercourse, pelvic pain or pain can also happen during sexual 
intercourse, menstruation periods sometimes last longer or are heavier than usual [21]; all of these symptoms 
may influence sexual functioning in CCS. The other reason is possibly because they were lack of cervical 
cancer-related knowledge. An exploratory study towards 16 women with cervical cancer showed that in the 
beginning they had low knowledge level, they experienced life crisis in term of physical disease, 
psychological stress, economic problems, and social isolation; it was proved that low knowledge level could 
result in worst cancer prevention and treatment [22].  
Stress due to cervical cancer treatments (55.32% severe stress) was found to be more severe than 
stress due to breast cancer treatments (34.48% severe stress). A prior study results showed that the type  
of therapy between cervical and breast cancer were significantly different with p = .000 [6]. Most CCS 
undertook more complex regiments, which is a combination of surgery and chemo-radiotherapy (36.17%)  
if compared to most BCS who undertook surgery only (44.83%). These findings indicate that most CCS 
experienced an invasive cervical cancer. More severe stress found in CCS possibly happened because regiments 
of cervical cancer have many side effects being a powerful stressor for women living with cervical cancer. 
 
 
Table 1. Demography characteristic 
Characteristic 
Cervical cancer (n=47) Breast cancer (n=58) 
Frequency % Frequency % 
1.    Age (years old) 











































































4.    Educational background 









b. Secondary school 
c. High school 

















































7.    Occupational status 
a.  Full-timer 
b.  Part-timer 
c.  Retired 
d.  Housewife 
e.  Seeking for a job 





















































8.    GDP per month 
a.  Less than minimum wage 
b.  Minimum wage - IDR 5 million 
c.  More than IDR 5 million 
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Table 2. Year of 1
st
 diagnosed with cancer, and the type of received therapy 
Characteristic 
Cervical cancer (n=47) Breast cancer (n=58) 
Frequency % Frequency % 
1.    Firstly diagnosed 
       a.  2018 
       b.  2017 
       c.  2016 
       d.  2015 
       e.  2014 





























2.    Type of therapy 
       a.  Surgery  
       b.  Chemotherapy 
       c.  Surgery+chemotherapy 
       d.  Surgery+radiotherapy 
       e.  Chemotherapy+radiotherapy 
       f.   Surgery+chemotherapy+radiotherapy 
       g.  Surgery+chemotherapy+radiotherapy+analgesic  
       h.  Surgery+chemotherapy+radiotherapy+medicine 
       i.   Surgery+chemotherapy+oral medicine  
       j.   Oral medicine (various types) 



















































Table 3. Stress, anxiety, depression, PLN, and fear in CCS and BC 
Characteristic 
Cervical cancer (n=47) Breast cancer (n=58) 
Frequency % Frequency % 
1.    Stress due to cancer diagnosis 
       a.  Severe  
       b.  Moderate 
       c.  Mild 





















2.    Stress due to cancer treatments 
       a.  Severe 
       b.  Moderate 
       c.  Mild 





















3.    Anxiety 
       a.  Severe 
       b.  Moderate 
       c.  Mild 





















4.   Depression 
       a.  Severe 
       b.  Moderate 
       c.   Mild 





















5.    PLN 
       a.  High 
       b.  Moderate 

















6.   Fear due to cancer recurrence 
       a.   Severe 
       b.   Moderate 
       c.   Mild 





















7.   Fear due to cancer metastasis 
       a.  Severe 
       b.  Moderate 
       c.  Mild 





















8.  Fear due to possibility of additional cancer 
       a.  Severe 
       b.  Moderate 
       c.  Mild 





















9.   Fear due to diagnostic test 
       a.  Severe 
       b.  Moderate 
       c.  Mild 





















*Category was made to ease the data presentation only, and not for statistical analysis purposes 
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Mean dif.  
(CI 95%) 




Mean SD Mean SD 
Stress due to cancer diagnosis 7.45 1.36 6.09 2.68 - -2.803 0.005 
Stress due to cancer treatments 6.55 1.85 4.90 2.84 - -2.926 0.003 
Anxiety 6.51 1.83 5.31 3.22 0.15–2.25 2.272 0.025 
Depression 5.74 2.36 2.64 3.31 - -4.533 0.000 
PLN 6.53 1.65 8.43 1.86 - -5.431 0.000 
Fear due to cancer reccurence 6.57 2.04 6.33 3.58 - -0.620 0.535 
Fear due to cancer metastasis 6.85 2.12 6.40 3.58 - -0.260 0.795 
Fear due to possibility of additional cancer 6.64 2.09 5.91 3.59 -0.45–1.90 1.225 0.223 
Fear due to diagnostic test 4.81 2.07 4.31 3.02 -0.53-0 1.52 0.963 0.338 
 
 
Table 5. Comparison of stress, anxiety, depression, PLN, and fear between stages  
of cancer survivorship in both cases 
A. Cervical cancer (n=47) 








Mean square (CI 
95%) 




Mean (sd) Mean (sd) Mean (sd) 
Stress due to cancer diagnosis 7.43(0.79) 7.56(1.41) 7.29(1.53) - 0.171 0.918 
Stress due to cancer treatments 7.43(0.53) 6.65(1.85) 6.06(2.11) - 2.819 0.224 
Anxiety 6.57(0.98) 6.87(1.79) 6.00(2.09) 3.711 1.116 0.337 
Depression 6.29(1.11) 6.26(2.03) 4.82(2.92) - 2.721 0.257 
PLN 7.00(1.53) 6.52(1.73) 6.35(1.66) - 1.316 0.518 
Fear due to cancer recurrence 6.29(1.38) 6.96(2.10) 6.18(2.19) - 2.584 0.275 
Fear due to cancer metastasis 7.00(1.41) 7.09(2.21) 6.47(2.27) - 1.680 0.432 
Fear due to possibility of additional cancer 6.57(1.40) 6.83(2.25) 6.41(2.18) 3.258 0.353 0.704 
Fear due to diagnostic test 5.57(1.81) 5.13(2.03) 4.05(2.11) 13.464 1.975 0.144 
B. Breast Cancer (n=58) 








Mean square  
(CI 95%) 




Mean (sd) Mean (sd) Mean (sd) 
Stress due to cancer diagnosis 6.05(2.39) 6.55(2.63) 5.50(3.12) - 1.484 0.476 
Stress due to cancer treatments 4.30(2.83) 5.55(3.05) 4.75(2.52) - 2.185 0.335 
Anxiety 5.80(3.46) 5.41(3.16) 4.56(3.08) 6.979 0.664 0.519 
Depression 3.05(3.82) 3.00(3.34) 1.63(2.47) - 1.916 0.384 
PLN 8.35(2.28) 8.00(1.80) 9.13(1.15) - 4.789 0.091 
Fear due to cancer recurrence 6.05(4.02) 6.95(3.46) 5.81(3.23) - 1.111 0.574 
Fear due to cancer metastasis 6.10(4.06) 6.95(3.47) 6.00(3.24) - 0.876 0.645 
Fear due to possibility of additional cancer 6.00(4.01) 6.18(3.43) 5.44(3.42) 2.679 0.858 0.430 
Fear due to diagnostic test 4.30(3.40) 4.86(3.03) 3.56(2.45) 7.843 0.202 0.818 
 
 
Cancer stage, tumor size and shape, age, overall health status, and the desire to have children  
in the future determine the ttreatment of cervical cancer [21]. Surgery in cervical cancer includes conization, 
total or radical hysterectomy, radical trachelectomy, and pelvic exenteration [21]; all of these types  
of surgery may influence the possibility to have children to some extends. Chemotherapy in cervical cancer 
uses certain chemicals aiming at killing cancer cells which are administered through intravenous injection  
or oral route; it may be combined with radiation, biologic drugs, or as a palliative therapy. The common side 
effects of chemotherapy are severe nausea and vomiting resulted in poor protein and caloric intake,  
even malnutrition [23, 24]. Other than that, alopecia or hair loss usually occurs because chemotherapy attacks 
rapidly the dividing hair matrix cells [25]. When some chemotherapy drugs are given intravenously, they can 
cause the skin and veins to become discolored or darker; itching or pruritus, the dryness, flaking, or peeling 
caused by chemotherapy usually goes away once chemotherapy is finished [26]. Changes to fingernails and 
toenails are common during chemotherapy. These changes include: yellowing, brittleness and cracking,  
lines across the nail, partial separation of nail from the nail bed, and darkening which happen evenly across 
the nail if chemotherapy is given continuously [27]. 
Radiation in cervical cancer includes external beam radiation, internal radiation (brachytherapy),  
or may be used as a palliative therapy [21]. Skin problems are common in patients receiving radiotherapy. 
Dest (2018) stated that during radiation therapy, the skin in the treatment area may look and feel like  
it is sunburned. How red and irritated the skin gets depends on the dose of radiation and how sensitive your 
skin cells are to the radiation. Radiation therapy can cause the skin to peel, especially in skin folds such  
as the buttocks, under the breasts and behind the ears. It can also easily peel in areas where the skin is thin, 
such as on the neck. Skin in the radiation treatment area can become swollen and puffy. Radiation recall,  
the side effect of radiotherapy, may happen shortly or sometime after the therapy; it could be months or year 
                       ISSN: 2252-8806 
Int. J. Public Health Sci, Vol. 9, No. 3, September 2020:  272 – 280 
278 
after it. It is a skin reaction by symptoms of reddish, tender, peel or blister like sunburns, which may also 
appear when certain chemotherapy drugs, e.g. Doxorubicin, are given after radiotherapy [28]. 
Because of significant differences were found between CCS and BCS regarding stress due to cancer 
diagnosis and treatments, therefore anxiety, depression, and PLN were also found to be significantly different 
between cases. Psychological stress was positively correlated with depression and anxiety in cancer, in which 
resilience partially mediated this correlation [29]. Therefore, resilience development should be included  
in the prevention of depression and anxiety in cancer treatment. More severe anxiety (53.19% severe anxiety) 
and more depressed women (55.32% severe depression) were found to live with cervical cancer in this study. 
This possibly happened because they had less hope, optimism, and general self-efficacy. A study towards 224 
cervical cancer patients showed that anxiety was higher in the period of 4-6 months after diagnosis and  
at stage II of the disease which may be predicted by hope and optimism; in the other hand, depression was 
also correlated with hope, optimism, and general self-efficacy [30]. 
In contrary, better PLN was found in women living with breast cancer (84.48% high PLN)  
due to lower level of stress, anxiety, and depression compared to CCS; even we found the absence of stress 
due to cancer diagnosis (5.17%) and its treatments (8.62%), no anxiety (10.34%), and no depression 
(39.66%). There are many factors influencing better outcomes in BCS, such as social support, age,  
and education level. Families were described as a primary source of multifaceted social support in BCS [31]. 
Reactions towards breast cancer was varied in women with older age (over the age of 65 years old) in which 
those reactions impacting their experiences in seeking social support at diagnosis and during treatment [32]. 
In this study we found BCS received more family support from their spouse, children, and parents;  
compared to from spouse and children only in CCS. In the other hand, younger women were found  
to be BCS in this study (mostly 31-60 years old) compared to CCS (mostly 41-70 years old). Most BCS also 
better educated than CCS (high school to university graduated vs. primary-secondary-high school graduated). 
A study towards 238 cancer survivors showed that social support mainly came from the family compared  
to other sources, the more family support received then the higher quality of life level and the more positive 
affect showed; special others support was strongly negative correlated with negative affect in women living 
with cancer; society support was strongly positive correlated with quality of life level in younger  
cancer survivors [33].  
Results also showed that stress due to cancer diagnosis and treatments, anxiety, depression,  
and PLN were not significantly different between survivorship stages both in CCS and BCS (all p > α).  
Prior study results showed that the time of first diagnosis was significantly different between CCS and BCS 
(p = .039), indicating significant difference also on the survivorship period between cases; time of first 
diagnosis was strongly correlated with the current stage of cancer (ρ = -.409; p=.000) [6]. Although there  
is a tendency that survivorship period was significantly different between CCS and BCS, but their stress, 
anxiety, depression, and PLN were not improved along with the survivorship stages. These findings indicate 
a very slow improvement of stress tolerance in CCS and BCS. This possibly happened because they need 
more time to do the adaptation process by responding towards the cancer-related stressors, and there  
is no exact limit of how long the adaptation process occurs in an individual, also there is no guarantee of low 
long they will survive. Individual response towards stressor may be influenced by physiological function, 
personality, and behavior characteristic [19]. In the case of female cancer, physiological function may impair 
to some extends. It could be reflected by clinical manifestations occur. Prior study results showed that more 
severe fatigue, appetite changes, pain, sleep disturbance, constipation, nausea-vomiting, and menstrual 
changes were found in CCS; in which overall physical wellbeing was significantly different between CCS 
and BCS (p<.001) [34]. By living with cancer for the rest of their life, it was hard for the respondents  
to eliminate their stress, depression, and anxiety due to cancer. In the other hand, personality and behavior 
characteristic were not identified in this study.  
Other than stress, fear also being a focus of this study. Results showed that fear towards cancer 
recurrence, metastasis, additional cancer, and diagnostic test were not significantly different between cases 
and survivorship stages in CCS and BCS (all p > α). These findings indicate that for women living with 
cancer, whatever the type of cancer is, cancer-related fear was similar; even there is no significant 
improvement in the long run of cancer survivorship. An exploratory study towards 30 BCS showed that 
higher fear towards cancer recurrence associated with pain, suffering, and death; they described using 
distraction and avoidance and fewer coping skills [35]. Another exploratory study towards 27 BCS showed 
that 49% respondents used passive or avoidant coping styles [36]. Lazarus & Folkman suggested there are 
two types of coping responses: emotion-focused and problem-focused coping [19]. It seemed that BCS who 
had fear especially towards cancer recurrence frequently used emotion-focused coping.  
Study about fear towards cancer metastasis, additional cancer, and diagnostic test is none  
to be found, opening a great chance for world researchers to conduct studies in these fields. Other than fear 
towards cancer recurrence, metastasis, additional cancer, and diagnostic test, a meta-synthesis study towards 
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78 studies from USA, UK, and Australia revealed what does people fear about cancer. Fear towards cancer 
may happen due to the core view of cancer as an unpredictable and indestructible enemy. Cancer may rise 
four types of fear: its proximity, the (lack of) strategies to keep it at a distance, the personal and social 
implications of succumbing, and dying from the disease [37]. More studies about fear was found in the area 
of breast cancer (41%) compared to cervical cancer (23%), also opening a great chance for world researchers 
to conduct studies in the area of cervical cancer.  
All study parameters were not significantly different between survivorship stages in CCS and BCS, 
indicating very slow improvement of stress/fear tolerance in the long run of survivorship, especially in 
women living with female cancer. By the end of this study, the big question about how long adaptation 
process happen and is there any maximum limit for that, in the context of women living with cervical or 
breast cancer, remains unanswered. If the adaptation process is limitless, then we could not see adaptation as 




Stress due to cancer diagnosis and treatments were significantly different between CCS and BCS, 
impacting significant differences on anxiety, depression, and PLN between cases. Stress due to cancer 
diagnosis and treatments, anxiety, depression, and PLN were not significantly different between survivorship 
stages both in CCS and BCS. Fear towards cancer recurrence, metastasis, additional cancer, and diagnostic 
test were not significantly different between cases and survivorship stages. Study findings indicate a very 
slow improvement in stress/fear tolerance in the long run of survivorship period. These study findings argue 
the existed adaptation theory because adaptation as a process was proved to be limitless in the context  
of women living with cancer, especially in term of psychological stress and fear, so that it will be very 
difficult to see adaptation as a product. Women living with cancer continuously need psychological support  
to reduce stress/fear response along the survivorship period. Community nurses need to collaborate with their 
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